Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quidelortho Corp (NQ: QDEL )

42.20 +2.52 (+6.35%)
Streaming Delayed Price Updated: 12:24 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Quidelortho Corp

< Previous 1 2 3 4 5 6 7 Next >
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Reports Second Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Report Second Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Reports First Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference
From QuidelOrtho Corporation
Via Business Wire
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its 
Via MarketBeat
Topics Initial Public Offering
Exposures COVID-19 Product Safety Securities Market
QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Present at the J.P. Morgan Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho and Runda Medical Form Joint Venture to Develop and Manufacture Assays for VITROS® Platform
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Announces Separation of Chairman and Chief Executive Officer Roles
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Host Investor Day on December 13, 2022
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Reports Third Quarter 2022 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022
From QuidelOrtho Corporation
Via Business Wire
Development of New Drugs to Target Lyme and Other Infectious Diseases Subject of a New Webinar Now Available From Quidel Corporation
From Quidel Corporation
Via Business Wire
QuidelOrtho to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
Quidel and World Champion Los Angeles Rams Partner to Combat COVID-19 and Promote Health Awareness in the L.A. Community
From Quidel Corporation
Via Business Wire
Bacterial Biofilms, Responsible for Up to 75% of All Infectious Diseases in America, Explored in New Webinar From Quidel Corporation
From Quidel Corporation
Via Business Wire
QuidelOrtho Announces $300 Million Share Repurchase Authorization
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Reports Second Quarter 2022 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Quidel Corporation and the American Heart Association join forces to Advance Education and Awareness of Heart Disease in San Diego County
From QuidelOrtho Corporation
Via Business Wire
Quidel Corp.—Developer of Only FDA-Cleared FIA Rapid Point-of-Care Diagnostic Lyme Disease Test—To Partner With Renowned Global Lyme Alliance to Dramatically Heighten Lyme Disease Awareness
From Quidel Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.